MACCE
Showing 1 - 25 of 498
Tertiary A-level Hospital Remote Intervention on MACCE,
Recruiting
- Stable Chronic Angina
- +2 more
- Intervention
- Control
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Science; National Cen
Oct 20, 2022
MACCE in Hospitalized Patients With Community-acquired Pneumonia
Recruiting
- Community-acquired Pneumonia
-
Rome, ItalyInternal and Medical Specialities Department - Policlinico Umber
Sep 28, 2021
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
Alzheimer, Alzheimer Related Dementias Trial in Pittsburgh (other, behavioral, procedure)
Not yet recruiting
- Alzheimer Disease
- Alzheimer Disease Related Dementias
- Personalized CPC Prehabilitation
- +7 more
-
Pittsburgh, PennsylvaniaUPMC Presbyterian Hospital
Sep 13, 2023
Prevention of Inappropriate Therapies and MACCE. Single-chamber ICD Trial in Spain (Single chamber DAI device with floating
Recruiting
- Prevention of Inappropriate Therapies and MACCE. Single-chamber ICD
- Single chamber DAI device with floating atrial dipole
-
Santiago De Compostela, A Coruña, Spain
- +15 more
Apr 12, 2020
High-Risk Percutaneous Coronary Intervention Trial (Impella ECP)
Recruiting
- High-Risk Percutaneous Coronary Intervention
- Impella ECP
-
Detroit, MichiganAscension St. John Hospital
Dec 23, 2022
Coronary Artery Disease Trial in Seoul (Clopidogrel treatment group, No antiplatelet or anticoagulant group)
Recruiting
- Coronary Artery Disease
- Clopidogrel treatment group
- No antiplatelet or anticoagulant group
-
Seoul, Other, Korea, Republic ofSeoul National University Hospital
May 9, 2023
Sarcopenia, Coronary Artery Disease Trial in Hong Kong (Resistance exercise)
Not yet recruiting
- Sarcopenia
- Coronary Artery Disease
- Resistance exercise
-
Hong Kong, Hong KongThe School of Nursing
Aug 9, 2022
Patients After PCI:a Multi-center Study
Recruiting
- hsCRP
-
Wuhan, Hubei, ChinaDepartment of Cardiology, Union Hospital, Tongji Medical College
Jan 1, 2023
Coronary Artery Disease Trial in Tashkent (DurVena Photochemical Tissue Passivation)
Not yet recruiting
- Coronary Artery Disease
- DurVena Photochemical Tissue Passivation
-
Tashkent, UzbekistanRepublican Scientific Center of Emergency Medical Care
Nov 27, 2023
Patients With Acute Myocardial Infarction Cohort
Recruiting
- Acute Myocardial Infarction
- Adverse Event
- Treatment Strategies
-
Beijing, Beijing, China
- +18 more
May 8, 2023
The Euro-CRAFT Registry
Recruiting
- Coronary Microvascular Disease
-
Aalst, Belgium
- +2 more
Mar 27, 2023
Ischemic Heart Disease, Valvular Heart Disease, Cardiovascular Diseases Trial (Hypothermic Cardiopulmonary Bypass, Normothermic
Not yet recruiting
- Ischemic Heart Disease
- +3 more
- Hypothermic Cardiopulmonary Bypass
- Normothermic Cardiopulmonary Bypass
- (no location specified)
Aug 10, 2023
Coronary Artery Disease Trial (Coronary artery bypass grafting based on conventional coronary angiography, Coronary artery
Not yet recruiting
- Coronary Artery Disease
- Coronary artery bypass grafting based on conventional coronary angiography
- Coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.
- (no location specified)
Sep 9, 2023
Cardiac Surgery, Enhanced Recovery After Surgery Trial in China (ERAS)
Not yet recruiting
- Cardiac Surgery
- Enhanced Recovery After Surgery
- ERAS
-
China, Beijing, China
- +1 more
Jun 12, 2023
Coronary Artery Bypass Grafting, Remote Ischemic Conditioning Trial in Xi'an (Remote ischemic conditioning)
Not yet recruiting
- Coronary Artery Bypass Grafting
- Remote Ischemic Conditioning
- Remote ischemic conditioning
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiantong University
Nov 15, 2023
Cardiac Tumor and Risk Stratification of Subsequent Adverse
Not yet recruiting
- Cardiac Tumor
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiantong University
Oct 19, 2023
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Embolism Trial (Emboliner Embolic Protection, Sentinel Cerebral Protection)
Not yet recruiting
- Embolism
- Emboliner Embolic Protection
- Sentinel Cerebral Protection
- (no location specified)
Jan 5, 2023
Severe Aortic Valve Stenosis Trial (ProtEmbo - Cerebral Embolic Protection, Sentinel - Cerebral Embolic Protection)
Not yet recruiting
- Severe Aortic Valve Stenosis
- ProtEmbo - Cerebral Embolic Protection
- Sentinel - Cerebral Embolic Protection
- (no location specified)
May 26, 2023
Treatment in Calcified Coronary Disease Trial (Intravascular Lithotripsy, Cutting Balloon)
Not yet recruiting
- Treatment in Calcified Coronary Disease
- Intravascular Lithotripsy
- Cutting Balloon
- (no location specified)
Oct 16, 2023
PCI in Beijing Friendship Hospital
Recruiting
- Cardiovascular Diseases
- Percutaneous Coronary Intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 6, 2023
Infective Endocarditis and Risk Stratification Value of
Not yet recruiting
- Infective Endocarditis
- Observational; No Interventions were given.
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiantong University
Jul 20, 2023
Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery Trial in Worldwide (Percuteneous Coronary Intervention,
Recruiting
- Ischemic Heart Disease
- Chronic Total Occlusion of Coronary Artery
- Percuteneous Coronary Intervention
- Optimal Medical Therapy
-
Aarhus N, Denmark
- +26 more
Jan 2, 2023